Celsius Holdings, Inc. (NASDAQ:CELH – Free Report) – Research analysts at B. Riley lifted their Q3 2023 earnings per share estimates for Celsius in a report released on Wednesday, August 9th. B. Riley analyst J. Van. Sinderen now expects that the company will post earnings of $0.35 per share for the quarter, up from their previous forecast of $0.27. The consensus estimate for Celsius’ current full-year earnings is $1.39 per share.
Celsius (NASDAQ:CELH – Get Free Report) last issued its quarterly earnings results on Tuesday, August 8th. The company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.26 by $0.26. The firm had revenue of $325.88 million for the quarter, compared to analyst estimates of $277.19 million. Celsius had a positive return on equity of 66.52% and a negative net margin of 11.60%. The company’s quarterly revenue was up 111.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.12 earnings per share.
Get Our Latest Stock Analysis on Celsius
Celsius Trading Up 1.2 %
Shares of CELH opened at $175.06 on Friday. Celsius has a 1 year low of $78.25 and a 1 year high of $178.76. The stock has a 50 day simple moving average of $146.50 and a 200-day simple moving average of $115.75. The stock has a market cap of $13.46 billion, a PE ratio of -91.89 and a beta of 1.82.
Insider Transactions at Celsius
In other news, major shareholder Hoi Shuen Solina Holly Chau sold 350,976 shares of the firm’s stock in a transaction on Wednesday, June 14th. The stock was sold at an average price of $142.46, for a total value of $50,000,040.96. Following the transaction, the insider now directly owns 7,980,323 shares in the company, valued at approximately $1,136,876,814.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Caroline S. Levy sold 2,200 shares of the firm’s stock in a transaction on Thursday, May 18th. The stock was sold at an average price of $134.51, for a total transaction of $295,922.00. Following the sale, the director now owns 17,605 shares of the company’s stock, valued at approximately $2,368,048.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder Hoi Shuen Solina Holly Chau sold 350,976 shares of the firm’s stock in a transaction on Wednesday, June 14th. The stock was sold at an average price of $142.46, for a total value of $50,000,040.96. Following the sale, the insider now directly owns 7,980,323 shares in the company, valued at approximately $1,136,876,814.58. The disclosure for this sale can be found here. 2.70% of the stock is owned by corporate insiders.
Institutional Trading of Celsius
Several hedge funds have recently added to or reduced their stakes in the business. Envestnet Asset Management Inc. raised its stake in shares of Celsius by 20.9% in the 1st quarter. Envestnet Asset Management Inc. now owns 5,908 shares of the company’s stock valued at $326,000 after purchasing an additional 1,023 shares during the period. JPMorgan Chase & Co. raised its stake in shares of Celsius by 8.5% in the 1st quarter. JPMorgan Chase & Co. now owns 54,953 shares of the company’s stock valued at $3,033,000 after purchasing an additional 4,285 shares during the period. Raymond James Financial Services Advisors Inc. raised its stake in shares of Celsius by 4.3% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 9,583 shares of the company’s stock valued at $529,000 after purchasing an additional 398 shares during the period. Bank of New York Mellon Corp raised its stake in shares of Celsius by 1.9% in the 1st quarter. Bank of New York Mellon Corp now owns 394,530 shares of the company’s stock valued at $21,771,000 after purchasing an additional 7,411 shares during the period. Finally, MetLife Investment Management LLC raised its stake in shares of Celsius by 53.1% in the 1st quarter. MetLife Investment Management LLC now owns 28,662 shares of the company’s stock valued at $1,582,000 after purchasing an additional 9,946 shares during the period. Institutional investors and hedge funds own 58.86% of the company’s stock.
About Celsius
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional drinks and liquid supplements in the United States and internationally. The company offers various carbonated and non-carbonated functional energy drinks under the CELSIUS Originals name; dietary supplement in carbonated flavors, including apple jack'd, orangesicle, inferno punch, cherry lime, blueberry pomegranate, strawberry dragon fruit, tangerine grapefruit, and jackfruit under the CELSIUS HEAT name; and branched-chain amino acids functional energy drink that fuels muscle recovery under the CELSIUS BCCA+ENERGY name.
Featured Stories
- Five stocks we like better than Celsius
- Stock Market Upgrades: What Are They?
- Investing in Coffee: 3 Great Strategies to Consider
- Why is the Ex-Dividend Date Significant to Investors?
- 5 Best Stocks to Buy in a Bear Market
- What to Know About Investing in Penny Stocks
- 3 Pharmaceutical Stocks to Buy and Hold for the Long Haul
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.
